期刊文献+

胶质瘤患者T淋巴细胞表面CTLA-4的表达及其临床意义 被引量:1

Expression of CTLA-4 in T lymphocytes of patients with glioma and its clinical significance
下载PDF
导出
摘要 目的:探讨胶质瘤患者外周血中CD4^+和CD8^+T细胞表面CTLA-4表达与胶质瘤WHO分级及手术的关系,阐明CTLA-4的临床意义。方法:选择本院胶质瘤患者60例作为胶质瘤组,健康志愿者46名作为健康对照组。流式细胞术检测胶质瘤组和健康对照组研究对象外周血中CD4+和CD8^+T细胞表面CTLA-4的表达,分析其与胶质瘤WHO分级及手术的关系。结果:胶质瘤组患者外周血CD4^+和CD8^+T细胞表面CTLA-4的表达水平明显高于对照组(P<0.01);Ⅳ级胶质瘤患者CD4^+和CD8^+T细胞表面CTLA-4表达水平最高,Ⅳ级胶质瘤患者CD4^+和CD8^+T细胞表面CTLA-4表达水平高于Ⅲ级胶质瘤(P<0.01),Ⅲ级胶质瘤患者CD4^+和CD8^+T细胞表面CTLA-4表达水平高于Ⅱ级胶质瘤(P<0.01);术后胶质瘤患者CD4^+和CD8^+T细胞表面CTLA-4表达水平低于术前(P<0.01)。结论:胶质瘤患者外周血CD4^+和CD8^+T细胞表面CTLA-4的表达水平随着胶质瘤恶性程度的升高而升高,并在胶质瘤发生发展过程中发挥促进作用。 Objective: To investigate the correlation between the CTLA-4 expression in the peripheral blood CD4+ and CD8+ T cells in the patients with glioma and glioma WHO classification and operation, and to clarify the clinical significances of CTLA-4. Methods: 60 patients with gIioma from our hospital were selected as glioma group, and 46 healthy volunteers were used as control group. Then the CTLA-4 expression levels in the peripheral blood CD4+ and CD8+ T ceils of the subjects in glioma group and control group were detected by fluorescence-activated cell sorting (FACS) and the relationship between CTLA-4 and glioma WHO classification and surgery was analyzed. Results: The CTLA-4 expression levels in CD4+ and CD8+ T cells in peripheral blood of the patients in glioma group were higher than those in control group (P〈0.01). The CTLA-4 expression level in the patients with grade IV glioma was the highest, the expression level of the patients with grade IV glioma was higher than that of the patients with grade HI glioma (P〈0.01), and the expression level of grade Ill the patients with was higher than that of the patients with grade II (P〈0.01). The expression level of CTLA 4 in CD4+ and CD8+T cells of the patients with glioma after operation was lower than before operation (P〈 0.01). Conclusion: The CTLA-4 expression levels in the peripheral blood CD4+ and CD8+ T cells are increased with the increasing of malignancy degree of the patients with glioma, and it has a promotion role in the occurrence of development of glioma.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2016年第2期311-315,共5页 Journal of Jilin University:Medicine Edition
基金 国家科技重大专项基金资助课题(320.6750.13339) 河南省科技厅科技攻关项目资助课题(142102310114)
关键词 胶质瘤 T淋巴细胞 细胞毒性T淋巴细胞相关抗原4 glioma T lymphocyte cytotoxic T-lymphocyte associated antigen-4
  • 相关文献

参考文献1

二级参考文献40

  • 1Luvero D, Milani A, Ledermann JA. Treatment options in recurrent ovarian cancer: latest evidence and clinical potential. TherAdv Med Onco12014; 6: 229-239.
  • 2Zsiros E, Tanyi J, Balint K, Kandalaft LE. Immunotherapy for ovarian cancer: recent advances and perspectives. CurrOpin 0ncol2014; 26: 492-500.
  • 3Yigit R, Massuger LF, Figdor CG, Torensma R. Ovarian cancer creates a suppressive microenvironment to escape immune elimination. Gynecol Onco12010; 117: 366-372.
  • 4Facciabene A, Motz GT, Coukos G. T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res 2012; 72: 2162-2171.
  • 5Viehl CT, Moore TT, Liyanage UK, Frey DM, Ehlers JP, Eberlein TJ et al. Depletion of CD4+CD25+ regulatory T cells promotes a tumor- specific immune response in pancreas cancer-bearing mice. Ann Surg 0ncol2006; 13: 1252-1258.
  • 6Liu S, Foulkes WD, Leung S, Gao D, Lau S, Kos Z et al. Prognostic significance of FOXP3+ tumor infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration. Breast Cancer Res 2014; 16: 432..
  • 7Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Onco12009; 27: 186-192.
  • 8Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, Wheeler TM et al. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Research 2007; 13: 6947-6958.
  • 9Li J, Huang ZF, Xiong G, Mo HY, Qiu F, Mai HQ et al. Distribution, characterization, and induction of CD8+ regulatory T cells and I L-17- producing CD8+ T cells in nasopharyngeal carcinoma. J Transl Med 2011..9: 189.
  • 10Alvarez Arias DA, Kim H J, Zhou P, Holderried TA, Wang X, Dranoff G et al. Disruption of CD8+ Treg activity results in expansion of T follicular helper cells and enhanced antitumor immunity. Cancer Immunol Res 2014; 2: 207-216.

共引文献16

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部